Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00351715
Recruitment Status : Terminated (Study stopped due to low accrual)
First Posted : July 13, 2006
Last Update Posted : January 28, 2013
Information provided by:
AHS Cancer Control Alberta

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2008
  Actual Study Completion Date : September 2008